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Abstract
Background: The aim of our study was to compare the presence of the intI1 gene and its
associations with the antibiotic resistance of commensal Escherichia coli strains in children with/
without previous antibiotic treatments and elderly hospitalized/healthy individuals.
Methods: One-hundred-and-fifteen intestinal E. coli strains were analyzed: 30 strains from 10
antibiotic-naive infants; 27 from 9 antibiotic-treated outpatient infants; 30 from 9 healthy elderly
volunteers; and 28 from 9 hospitalized elderly patients. The MIC values of ampicillin, cefuroxime,
cefotaxime, gentamicin, ciprofloxacin, and sulfamethoxazole were measured by E-test and IntI1 was
detected by PCR.
Results: Out of the 115 strains, 56 (49%) carried class 1 integron genes. Comparing persons
without medical interventions, we found in antibiotic-naive children a significantly higher frequency
of integron-bearing strains and MIC values than in healthy elderly persons (53% versus 17%; p <
0.01). Evaluating medical interventions, we found a higher resistance and frequency of integrons in
strains from hospitalized elderly persons compared with non-hospitalized ones. Children treated
with antibiotics had strains with higher MIC values (when compared with antibiotic-naive ones), but
the integron-bearing in strains was similar. In most cases, the differences in resistance between the
groups (integron-positive and negative strains separately) were higher than the differences between
integron-positive and negative strains within the groups.
Conclusion: The prevalence of integrons in commensal E. coli strains in persons without previous
medical intervention depended on age. The resistance of integron-carrying and non-carrying strains
is more dependent on influencing factors (hospitalization and antibiotic administration) in particular
groups than merely the presence or absence of integrons.
Published: 8 December 2009
Annals of Clinical Microbiology and Antimicrobials 2009, 8:34 doi:10.1186/1476-0711-8-34
Received: 15 September 2009
Accepted: 8 December 2009
This article is available from: http://www.ann-clinmicrob.com/content/8/1/34
© 2009 Sepp et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Annals of Clinical Microbiology and Antimicrobials 2009, 8:34 http://www.ann-clinmicrob.com/content/8/1/34
Page 2 of 6
(page number not for citation purposes)
Background
Escherichia coli is one of the most common bacteria in the
environment and in the intestinal tract of humans and
animals [1-3]. The intensive use of antibiotics in both
human and veterinary medicine, as well as in the field of
agriculture, is associated with an emerging resistance
against therapeutic drugs, followed by the selection of vir-
ulence and resistance gene cassettes (such as integrons)
carrying E. coli strains in humans, animals, and the envi-
ronment [4-6].
Integrons are ancient structures that contain determinants
of a site-specific recombination system to capture genes
encoding antimicrobial resistance [7]. They can locate
within transposons or conjugative plasmids and contrib-
ute to the gene traffic leading to the acquisition of new
genes in bacteria [8-13].
The class 1 integron is prevalent on plasmids. It has been
found in both gram-positive and especially in gram-nega-
tive bacteria like Enterobacteriaceae, Campylobacter spp.,
Acinetobacter spp., Pseudomonas spp., Aeromonas spp., and
Vibrio spp. [13-16]. The prevalence of the class 1 integron
in clinical E. coli strains is 33 to 49% [10,17-20].
Class 1 integrons carrying commensal E. coli strains have
been isolated from 11%-42% of healthy adult persons
[17,19,21]. The high prevalence of the intI1 gene among
the intestinal E. coli suggests that commensals could rep-
resent an important reservoir of resistance determinants,
where gene cassettes could spread between commensal
and pathogenic bacteria [1].
Still, there are few data assessing the association between
integron carriage and the antimicrobial resistance patterns
of E. coli isolated from the commensal gut microbiota of
different age groups like infants and elderly persons
[17,19,21,22].
We aimed to compare the presence of the intI1 gene and
its association with the antibiotic resistance of commensal
E. coli strains in patients of different age groups: children
with/without previous antibiotic treatment and elderly
hospitalized/healthy individuals.
Methods
Subjects
Four groups of subjects were included into the study:
(Group 1) antibiotic-naive infants (n = 10; age 3-12
months; mean 7.5 months); (Group 2) antibiotic-treated
outpatient infants (n = 9; age 1 week-12 months; mean
7.4 months); (Group 3) healthy elderly volunteers (n = 9;
age 68-80 years; mean 73 years), and; (Group 4) elderly
hospitalized patients (n = 9; age 65-77 years; mean 70
years). All children were vaginally born at the Women's
Clinic of Tartu University Hospital and were randomly
selected from the participants of a prospective study on
the bias of data concerning previous antibiotic treatment
[23]. The healthy volunteers, randomly selected from a
registry of general practitioners in Tartu, were considered
to be healthy, had not been following any special dietary
routines and had not received antibiotic treatment for at
least two months prior to inclusion. The hospitalized eld-
erly, without clinical signs indicating inflammatory dis-
ease, were randomly recruited from the Department of
Orthopaedics of Tartu University Hospital two to three
days before scheduled orthopaedic surgery and had not
received antibiotics during the previous two months.
Faecal samples
From 27 persons, approximately 1 gram of freshly voided
stool was collected into sterile plastic containers and fro-
zen at -20°C. Weighed samples of faeces were serially
diluted (10-2-10-9) in a pre-reduced phosphate buffer (pH
7.2). A quantitative analysis of the gut bacteria was per-
formed using seeding duplicate samples of 0.1 ml of each
dilution on MacConkey (Oxoid, England) agar plates. The
colony counts of the different faecal dilutions were
recorded, and all colonies of different morphology from
the highest dilutions with growth were isolated and iden-
tified with the standard methods. From each sample (n =
27), 3-4 fenotypically different dominating E. coli isolates
were included. In total, 115 isolates were collected and
analyzed.
Antibiotic resistance
Antimicrobial susceptibility testing was performed using
the E-test (AB Biodisk, Solna, Sweden) on Mueller-Hinton
agar (Oxoid, UK). The values of the minimal inhibitory
concentration (MIC) of E. coli isolates to ampicillin,
cefuroxime, cefotaxime, gentamicin, ciprofloxacin, and
sulfamethoxazole were determined according to the man-
ufacturer's instructions and to Clinical and Laboratory
Standard Institute guidelines.
Detection of the class 1 integrons
All E. coli isolates were tested for the presence of class 1
integrons with a polymerase chain reaction (PCR) ampli-
fication of a class 1 integrase-specific fragment of the intI1
gene. The total DNA of the E. coli was extracted using a
QIAamp DNA Mini Kit (Qiagen, Germany) following the
manufacturer's protocol for gram-negative bacteria. The
primer sequences used were 5'CS: 5'-GGCATCCAAGCAG-
CAAG-3' and 3'CS: 5'-AAGCAGACTTGACCTGA-3' [24].
The reactions were carried out in a volume of 50-μl con-
taining 10× PCR buffer, 2.5 mM MgCl2, 2.5 mM dNTPs, 5
pmol/L each primer, 2.5 U Taq polymerase (Fermentas,
Lithuania), and 1 μg of template DNA was added. Ampli-
fication specifications were as follows: 94°C for 5 min.
followed by 35 cycles of 94°C for 30 sec., 55°C for 30 sec.,Annals of Clinical Microbiology and Antimicrobials 2009, 8:34 http://www.ann-clinmicrob.com/content/8/1/34
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72°C for 30 sec. and the final extension at 72°C for 7 min.
The amplicons were electrophorezed in 1.0% agarose gel
and the 1 kb ladder (Fermentas, Lithuania) was used as a
molecular size marker.
Statistical analysis
The statistical analyses were performed using the SigmaS-
tat (Jandel Scientific, USA) and Excel (Microsoft Corp.)
software programs, employing the Fisher exact test, the
chi-square test, and the Mann-Whitney rank sum test. P
values less than 0.05 were considered statistically signifi-
cant.
Approval by ethics committee
The Ethics Committee of Tartu University Medical Faculty
approved the study (No. 139/16 20.06.2005 and No.
152/52 18.09.2006).
Results
Prevalence of class 1 integrons in E. coli isolates in 
different study groups
Out of the 115 dominating commensal E. coli isolates, 56
(49%) carried the intI1 gene. We found a similarly high
rate of integrons among dominating E. coli isolates in anti-
biotic-treated (Group 2; 17/27; 63%) and non-treated
(Group 1; 16/30; 53%) infants, as well as in hospitalized
elderly patients (Group 4; 18/28; 64%). In elderly healthy
volunteers (Group 3), the integron-positive isolates were
comparatively low among the dominating E. coli popula-
tion (5/30; 17%; p < 0.01; Table 1).
Antibiotic susceptibility of E. coli isolates
Comparing different age groups not influenced by medi-
cal intervention, we found that dominating E. coli isolates
originating from antibiotic-naive infants (Group1) had
higher MIC values to sulfamethoxazole (p < 0.001), cefo-
taxime (p = 0.003), gentamicin (p < 0.001), and cipro-
floxacin (p < 0.001) than those originating from healthy
elderly persons (Group3).
To evaluate the influence of medical interventions on
dominating E. coli populations, we compared the MIC
values of isolates of antibiotic-naive versus treated infants
and healthy elderly persons versus hospitalized. The iso-
lates from antibiotic-treated infants (Group2) were more
resistant to different antibiotics (range 0-5, median 2 ver-
sus range 0-3, median 1; p = 0.025) and had higher MIC
values to sulfamethoxazole (p = 0.048), cefuroxime (p <
0.001), cefotaxime (p = 0.013), gentamicin (p = 0.003),
and ciprofloxacin (p = 0.002), compared to antibiotic-
naive infants (Group1). In isolates from hospitalized
patients (Group 4), the resistance to tested antibiotics
(range 0-6, median 1 versus range 0-2 median 0; p = 0.01)
and MIC values were higher to sulfamethoxazole (p <
0.001), ampicillin (p < 0.001), cefuroxime (p < 0.001),
cefotaxime (p < 0.001), and ciprofloxacin (p < 0.001),
when compared to their outpatient counterparts (Group
3).
Relation between the presence of the intI1 gene and 
antibiotic susceptibility
In comparing strains from all the groups together, the
MIC-s of intI1-positive isolates were significantly higher
than integron-negative ones in the case of several antibi-
otics (sulfamethoxazole, p = 0.001; ampicillin, p < 0.001;
cefuroxime, p = 0.003; cefotaxime, p < 0.001; cipro-
floxacin, p = 0.038). However, in comparing the MIC val-
ues of intI1-positive and negative isolates in particular
groups, we found a significant difference only in non-
treated infants (Group 1) in the case of cefotaxime (p =
0.023). Comparing only intI1-negative isolates, we found
significantly higher MIC values in groups with medical
interventions (i.e. antibiotic-treated infants and hospital-
ized patients versus non-treated infants and non-hospital-
ized patients). Similar trends were also evident if only
intI1-positive isolates were compared (Table 2). Thus, dif-
ferences in MIC values were related to age in groups with-
out medical interventions (infants versus elderly) and
with medical interventions (antibiotic treatment and hos-
pitalization), but not to the carriage or absence of inte-
grons within a particular group. Figure 1 shows the
cumulative MIC values of different groups in the case of
cefuroxime.
Discussion
We found a significantly higher frequency of the intI1
gene in the dominating intestinal E. coli populations in
healthy antibiotic-naive children (Group 1; 53%) com-
Table 1: Prevalence of class 1 integrons among studied persons and E. coli isolates
Infants Elderly
Group1 Group2 Group3 Group4
Persons with integrons/total (%) 7/10 (70%) 8/9 (89%) 3/9 (33%) 8/9 (89%)
Isolates with integrons/total (%) 16/30 (53%) 17/27 (63%) 5/30 (17%) 18/28 (64%)
P values for comparisons between groups have been shown in the text.Annals of Clinical Microbiology and Antimicrobials 2009, 8:34 http://www.ann-clinmicrob.com/content/8/1/34
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Table 2: MIC50 values of intestinal dominant E. coli population in studied groups
Antibiotics MIC50 (mg/L) of all isolates
MIC50 of integron-negative/integron-positive isolates
Statistical significance*
Children Elderly
Group 1 Group 2 Group 3 Group 4
Ampicillin 5
31/7
6
101/6
2
22/256
6
62/36
1 p = 0.05
2 p = 0.001
Cefuroxime 2
21/2.52
6
61/82
2
23/24
6
53/64
1 p < 0.001
2 p < 0.001
3 p < 0.001
4 p < 0.001
Cefotaxime 0.064
0.0321/0.094
0.125
0.1251/0.125
0.047
0.0472/0.0473
0.125
0.1252/0.1253
1 p = 0.028
2 p < 0.001
3 p = 0.001
Gentamicin 0.38
0.38/0.441
1.5
1.0/1.51
0.5
0.5/0.38
0.38
0.38/0.38
1 p = 0.011
Ciprofloxacin 0.012
0.012/0.0121
0.023
0.023/0.0231
0.008
0.0082/0.0123
0.016
0.0162/0.0163
1 p = 0.004
2 p < 0.001
3 p = 0.048
Sulfamethoxazole 512
20/512
512
512/512
24
241/512
64
2281/56
1 p = 0.03
*Statistical significance (by the Mann-Whitney test) has been shown separately for integron-positive and negative strains comparing groups with 
medical intervention to groups without intervention (i.e. antibiotic-naive children versus treated ones; hospitalized elderly versus non-hospitalized). 
P values for the comparison of the other groups have been shown in the text.
Cumulative MIC values of cefuroxime Figure 1
Cumulative MIC values of cefuroxime. red lines/marks - integron-positive strains; blue lines/marks - integron-negative 
strains; triangles - strains of children; squares - strains of adults; dotted line - strains of uninfluenced persons (antibiotic-naive 
children or healthy elderly); continuous line - strains of persons with medical interventions (antibiotic-treated children or hos-
pitalized elderly).
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pared to healthy elderly persons (Group3; 17%). The MIC
values for several antibiotics for dominant E. coli isolates
were lower in elderly persons than in children. Although
some previous studies have shown variations of integron
prevalence in E. coli isolates from the intestinal tracts of
healthy persons, no significant differences in different age
groups (not influenced by antibiotics and hospitaliza-
tion) in the same region has been described yet
[5,21,22,25].
Our finding is somewhat surprising, since one can assume
a higher rate of resistant and integron-containing bacteria
in older people due to the selective pressure of antibiotics
consumed during a lifespan. The possible explanation is
that in young children (<1 years), the gastrointestinal
micro-ecosystem is not yet fully completed and coloniza-
tion resistance (supported by anaerobes, lactobacilli, and
other endogenous commensal bacteria) against exoge-
nous bacteria is weaker; hence, they may be colonized by
high numbers of E. coli strains from the environment,
containing different virulence or resistance genes, e.g.
integrons. Furthermore, during the development of com-
mensal intestinal microflora, the strains without resist-
ance probably have advantages in microbial competition
in the intestinal micro-ecosystem, and due to the fitness
cost the resistant population would be suppressed (in the
case of the absence of an antibiotic pressure) [26].
Comparing the dominating E. coli populations of antibi-
otic-naive and antibiotic-influenced infants, we found a
similar high rate in the presence of class 1 integrons. How-
ever, the resistance of E. coli was significantly higher in
antibiotic-treated infants. Our results indicate that the
higher resistance in antibiotic-treated infants is probably
mediated by integron-independent mechanisms, or the
expression of resistance genes in integrons is due to anti-
biotic consumption.
We found that the dominating E. coli population in the
intestinal tracts of hospitalized elderly patients was more
resistant and more frequently harbored integrons than did
those in healthy persons. However, this resistance was not
mainly integron-mediated, since similar differences in
MIC values were found when separately comparing inte-
gron-positive and negative isolates. The published data
concerning the prevalence of integrons in E. coli strains
isolated from a hospital and community are contradic-
tory. Some investigators have found that higher numbers
of integron-positive isolates originated from patients of
intensive care units, when compared to non-intensive care
unit ones and outpatients (82% versus 10% and 8%) [25].
To the contrary, Lee and co-workers indicated that the
prevalence of class 1 integrons among commensal E. coli
isolates was similar to that of clinical E. coli isolates from
hospital-acquired infections [27].
Increasing resistance in the dominating populations of
intestinal bacteria could be caused by the acquisition of
resistant and/or integron-positive strains from the hospi-
tal environment or by the overgrowth of normally sup-
pressed resistant populations. In both cases, the
disruption of commensal microflora responsible for the
maintenance of colonization resistance is a conducive fac-
tor. This can happen due to a recent exposure to antibiot-
ics, a different diet, increased hygiene habits, and a
stressful situation, in essence describing a hospital envi-
ronment [23,26,28]. It has been previously indicated that
exposure to stress results in a significant alteration of
intestinal microflora: the counts of beneficial bacteria
decrease and enterobacteria like E. coli increase [29,30].
In our study, all integron-positive isolates together had
higher MIC values to antibiotics than integron-negative
isolates, but susceptibility was similar in studied particu-
lar groups. In previous studies, resistant phenotypes usu-
ally correlated with the presence of integrons [25,31,32].
Several studies have described the association between the
presence of class 1 integrons and non-susceptibility to sul-
famethoxazole,  β-lactams (ampicillin, piperacillin,
cefuroxime), aminoglycosides (gentamicin, tobramycin),
and fluoroquinolone (ciprofloxacin) in E. coli strains
[20,24]. It has been supposed that the screening of inte-
grons could assist in guiding treatment regimens and
could complement existing antibiotic resistance surveil-
lance programs by providing information about both
aspects: resistance and its dissemination between com-
mensal and infectious strains [32]. On the one hand, the
absence of significant differences in resistance between
integron-positive and negative isolates within particular
groups in our study may be explained with the small
number of strains/persons. However, on the other hand,
significant differences in resistance between these groups
(separately comparing integron-positive and negative iso-
lates) indicate that the presence of integrons is not impor-
tant for the predisposition or correlation of the general
antimicrobial resistance. Thus, other factors are more
important in determining the resistance of the predomi-
nant population of E. coli and probably other facultative
pathogens as well. For a more complete understanding of
these results, further studies detecting particular resistance
genes and the presence of empty integrons are needed.
Conclusion
In our study, the prevalence of the intl1 gene in commen-
sal E. coli isolates differs between age groups and depends
on hospitalization. Resistance (to the antibiotics selected
in our study) of intl1-carrying and non-carrying isolates is
more dependent on the influencing factors (such as hos-
pitalization or antibiotic administration) on particular
groups than merely the presence or absence of integrons.Annals of Clinical Microbiology and Antimicrobials 2009, 8:34 http://www.ann-clinmicrob.com/content/8/1/34
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